

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | viral transcription (GO:0019083) | 8.06091136 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 7.79534962 |
| 3 | translational termination (GO:0006415) | 7.69991434 |
| 4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.78976187 |
| 5 | ribosomal small subunit biogenesis (GO:0042274) | 6.77129855 |
| 6 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.76171384 |
| 7 | cotranslational protein targeting to membrane (GO:0006613) | 6.72227655 |
| 8 | translational elongation (GO:0006414) | 6.66847362 |
| 9 | protein targeting to ER (GO:0045047) | 6.64164168 |
| 10 | ATP synthesis coupled proton transport (GO:0015986) | 6.43317098 |
| 11 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.43317098 |
| 12 | protein localization to endoplasmic reticulum (GO:0070972) | 6.35560992 |
| 13 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 6.34851440 |
| 14 | maturation of SSU-rRNA (GO:0030490) | 6.06031075 |
| 15 | cellular protein complex disassembly (GO:0043624) | 6.02930288 |
| 16 | viral life cycle (GO:0019058) | 5.97721407 |
| 17 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.69085922 |
| 18 | ribosomal large subunit biogenesis (GO:0042273) | 5.68839888 |
| 19 | translational initiation (GO:0006413) | 5.57107040 |
| 20 | NADH dehydrogenase complex assembly (GO:0010257) | 5.24482083 |
| 21 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 5.24482083 |
| 22 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 5.24482083 |
| 23 | protein complex disassembly (GO:0043241) | 5.20672402 |
| 24 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.04994156 |
| 25 | macromolecular complex disassembly (GO:0032984) | 4.94914616 |
| 26 | protein complex biogenesis (GO:0070271) | 4.92178931 |
| 27 | respiratory electron transport chain (GO:0022904) | 4.90306006 |
| 28 | electron transport chain (GO:0022900) | 4.83347695 |
| 29 | behavioral response to nicotine (GO:0035095) | 4.81240667 |
| 30 | DNA deamination (GO:0045006) | 4.78098046 |
| 31 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.67637043 |
| 32 | translation (GO:0006412) | 4.52298703 |
| 33 | chaperone-mediated protein transport (GO:0072321) | 4.47918873 |
| 34 | protein targeting to membrane (GO:0006612) | 4.42654328 |
| 35 | GTP biosynthetic process (GO:0006183) | 4.41641157 |
| 36 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.19623006 |
| 37 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 4.13991349 |
| 38 | proteasome assembly (GO:0043248) | 4.12524027 |
| 39 | mRNA catabolic process (GO:0006402) | 3.92783439 |
| 40 | UTP biosynthetic process (GO:0006228) | 3.92539059 |
| 41 | respiratory chain complex IV assembly (GO:0008535) | 3.89819620 |
| 42 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.89209659 |
| 43 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.87460076 |
| 44 | cellular component biogenesis (GO:0044085) | 3.85179896 |
| 45 | platelet dense granule organization (GO:0060155) | 3.69485596 |
| 46 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.69380125 |
| 47 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.65019335 |
| 48 | termination of RNA polymerase III transcription (GO:0006386) | 3.65019335 |
| 49 | RNA catabolic process (GO:0006401) | 3.60482964 |
| 50 | inner mitochondrial membrane organization (GO:0007007) | 3.60378578 |
| 51 | base-excision repair, AP site formation (GO:0006285) | 3.56667133 |
| 52 | oxidative phosphorylation (GO:0006119) | 3.56110156 |
| 53 | regulation of mitochondrial translation (GO:0070129) | 3.53461641 |
| 54 | UTP metabolic process (GO:0046051) | 3.52594989 |
| 55 | CTP metabolic process (GO:0046036) | 3.49937226 |
| 56 | CTP biosynthetic process (GO:0006241) | 3.49937226 |
| 57 | positive regulation of prostaglandin secretion (GO:0032308) | 3.48356181 |
| 58 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.47440018 |
| 59 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.45634535 |
| 60 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.45046017 |
| 61 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.44559863 |
| 62 | daunorubicin metabolic process (GO:0044597) | 3.41970458 |
| 63 | polyketide metabolic process (GO:0030638) | 3.41970458 |
| 64 | doxorubicin metabolic process (GO:0044598) | 3.41970458 |
| 65 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.40097323 |
| 66 | dopamine transport (GO:0015872) | 3.38975860 |
| 67 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.37631550 |
| 68 | protein targeting to mitochondrion (GO:0006626) | 3.35156420 |
| 69 | pseudouridine synthesis (GO:0001522) | 3.34213611 |
| 70 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.33267408 |
| 71 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.32923312 |
| 72 | DNA damage response, detection of DNA damage (GO:0042769) | 3.32377342 |
| 73 | establishment of integrated proviral latency (GO:0075713) | 3.31642621 |
| 74 | negative regulation of telomere maintenance (GO:0032205) | 3.30354898 |
| 75 | mannosylation (GO:0097502) | 3.24706460 |
| 76 | negative regulation of ligase activity (GO:0051352) | 3.23286358 |
| 77 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.23286358 |
| 78 | rRNA processing (GO:0006364) | 3.23036906 |
| 79 | ubiquinone biosynthetic process (GO:0006744) | 3.22151209 |
| 80 | establishment of protein localization to membrane (GO:0090150) | 3.20289374 |
| 81 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.20042616 |
| 82 | autophagic vacuole fusion (GO:0000046) | 3.19891292 |
| 83 | DNA strand elongation (GO:0022616) | 3.19647335 |
| 84 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.18225968 |
| 85 | protein targeting (GO:0006605) | 3.17504586 |
| 86 | ATP biosynthetic process (GO:0006754) | 3.17447405 |
| 87 | establishment of protein localization to mitochondrion (GO:0072655) | 3.17237003 |
| 88 | cellular response to interferon-beta (GO:0035458) | 3.15354342 |
| 89 | hydrogen ion transmembrane transport (GO:1902600) | 3.14117271 |
| 90 | rRNA metabolic process (GO:0016072) | 3.11004639 |
| 91 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.10449277 |
| 92 | spliceosomal snRNP assembly (GO:0000387) | 3.10344166 |
| 93 | cytochrome complex assembly (GO:0017004) | 3.08170710 |
| 94 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.07042189 |
| 95 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.07042189 |
| 96 | response to misfolded protein (GO:0051788) | 3.05929597 |
| 97 | aerobic respiration (GO:0009060) | 3.04803493 |
| 98 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.03679123 |
| 99 | peptidyl-histidine modification (GO:0018202) | 3.03674684 |
| 100 | deoxyribose phosphate catabolic process (GO:0046386) | 3.03340390 |
| 101 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.02925855 |
| 102 | metallo-sulfur cluster assembly (GO:0031163) | 3.02845970 |
| 103 | iron-sulfur cluster assembly (GO:0016226) | 3.02845970 |
| 104 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.02709676 |
| 105 | response to interferon-beta (GO:0035456) | 3.02533491 |
| 106 | deoxyribonucleotide catabolic process (GO:0009264) | 3.01078032 |
| 107 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.00852973 |
| 108 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.99717598 |
| 109 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.98889279 |
| 110 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.98282677 |
| 111 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.98031776 |
| 112 | spliceosomal complex assembly (GO:0000245) | 2.96461237 |
| 113 | negative regulation of B cell apoptotic process (GO:0002903) | 2.96203616 |
| 114 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.94990373 |
| 115 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.94615591 |
| 116 | protein localization to mitochondrion (GO:0070585) | 2.94054540 |
| 117 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.92156041 |
| 118 | proton transport (GO:0015992) | 2.91848579 |
| 119 | positive regulation of T cell apoptotic process (GO:0070234) | 2.89199546 |
| 120 | hydrogen transport (GO:0006818) | 2.85477495 |
| 121 | positive regulation of fatty acid transport (GO:2000193) | 2.84628154 |
| 122 | positive regulation of defense response to virus by host (GO:0002230) | 2.81621163 |
| 123 | positive regulation of icosanoid secretion (GO:0032305) | 2.78953655 |
| 124 | ubiquinone metabolic process (GO:0006743) | 2.78661184 |
| 125 | fucose catabolic process (GO:0019317) | 2.78313936 |
| 126 | L-fucose metabolic process (GO:0042354) | 2.78313936 |
| 127 | L-fucose catabolic process (GO:0042355) | 2.78313936 |
| 128 | tryptophan catabolic process (GO:0006569) | 2.76083755 |
| 129 | indole-containing compound catabolic process (GO:0042436) | 2.76083755 |
| 130 | indolalkylamine catabolic process (GO:0046218) | 2.76083755 |
| 131 | protein neddylation (GO:0045116) | 2.72816793 |
| 132 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.70970883 |
| 133 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.70970883 |
| 134 | protein-cofactor linkage (GO:0018065) | 2.70143821 |
| 135 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.68967270 |
| 136 | kynurenine metabolic process (GO:0070189) | 2.67773609 |
| 137 | indolalkylamine metabolic process (GO:0006586) | 2.65436423 |
| 138 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.65313476 |
| 139 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.61262605 |
| 140 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.60274389 |
| 141 | sequestering of actin monomers (GO:0042989) | 2.59744956 |
| 142 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.59126942 |
| 143 | cellular biogenic amine catabolic process (GO:0042402) | 2.58873300 |
| 144 | amine catabolic process (GO:0009310) | 2.58873300 |
| 145 | tRNA processing (GO:0008033) | 2.57600736 |
| 146 | opioid receptor signaling pathway (GO:0038003) | 2.55451037 |
| 147 | organelle membrane fusion (GO:0090174) | 2.55179196 |
| 148 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.54587297 |
| 149 | cellular response to exogenous dsRNA (GO:0071360) | 2.53129288 |
| 150 | intracellular protein transmembrane import (GO:0044743) | 2.52989816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.98373339 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.87990657 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.26222831 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.96683261 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.93883513 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.85557224 |
| 7 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.83014536 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.64149805 |
| 9 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.63317805 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.56101667 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.43272705 |
| 12 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.31736340 |
| 13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.03525361 |
| 14 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.93310804 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.75058595 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.65842039 |
| 17 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.56958377 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.55538104 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.55259227 |
| 20 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.47054260 |
| 21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.44130070 |
| 22 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.38640620 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.37816560 |
| 24 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.36593674 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.34597771 |
| 26 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.33895022 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.31042465 |
| 28 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29849928 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.25284503 |
| 30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.22702253 |
| 31 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.20579050 |
| 32 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.20488827 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.19822990 |
| 34 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.13858645 |
| 35 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.11536513 |
| 36 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.08943095 |
| 37 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.05035779 |
| 38 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.91795247 |
| 39 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.91431111 |
| 40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.86944258 |
| 41 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.86554484 |
| 42 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.82554749 |
| 43 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.80386024 |
| 44 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.79394381 |
| 45 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.76359956 |
| 46 | P68_20966046_ChIP-Seq_HELA_Human | 1.75256083 |
| 47 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.74560918 |
| 48 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.74308705 |
| 49 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.67265473 |
| 50 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.67018773 |
| 51 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.66921385 |
| 52 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.64402201 |
| 53 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.62322324 |
| 54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.61360955 |
| 55 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.61230978 |
| 56 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.59941993 |
| 57 | ERA_21632823_ChIP-Seq_H3396_Human | 1.59408547 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55103323 |
| 59 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.54964479 |
| 60 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.54937623 |
| 61 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.54092592 |
| 62 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.52426038 |
| 63 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52021998 |
| 64 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.50227218 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50139614 |
| 66 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.47585186 |
| 67 | P300_27268052_Chip-Seq_Bcells_Human | 1.46743041 |
| 68 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.46238094 |
| 69 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.45577594 |
| 70 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.45552023 |
| 71 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.45042371 |
| 72 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.44707516 |
| 73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.42506686 |
| 74 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.42214390 |
| 75 | VDR_22108803_ChIP-Seq_LS180_Human | 1.41670629 |
| 76 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.41033277 |
| 77 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.40076843 |
| 78 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.36085130 |
| 79 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.34978512 |
| 80 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.34610833 |
| 81 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34311251 |
| 82 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.31298984 |
| 83 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.29178870 |
| 84 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.28262580 |
| 85 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26227508 |
| 86 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.26197554 |
| 87 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.25444428 |
| 88 | SA1_27219007_Chip-Seq_Bcells_Human | 1.25281848 |
| 89 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.24091372 |
| 90 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.24023860 |
| 91 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.22835743 |
| 92 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.20527918 |
| 93 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.20006146 |
| 94 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.19511092 |
| 95 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.19350262 |
| 96 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18201066 |
| 97 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.17889561 |
| 98 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.17362257 |
| 99 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17319377 |
| 100 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.17085852 |
| 101 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15364893 |
| 102 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.15056497 |
| 103 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14108025 |
| 104 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.13286734 |
| 105 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.12541283 |
| 106 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12518622 |
| 107 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.10715302 |
| 108 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.09674721 |
| 109 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09047786 |
| 110 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.08854645 |
| 111 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.08469543 |
| 112 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.08170665 |
| 113 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.06251688 |
| 114 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.05940382 |
| 115 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.05579745 |
| 116 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04940531 |
| 117 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.03467677 |
| 118 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00960583 |
| 119 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99906761 |
| 120 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.99010975 |
| 121 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.98710830 |
| 122 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.98398727 |
| 123 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98011708 |
| 124 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.96639577 |
| 125 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.94879259 |
| 126 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93051485 |
| 127 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.89834450 |
| 128 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.89021287 |
| 129 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.88195403 |
| 130 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.88125637 |
| 131 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88078943 |
| 132 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87681934 |
| 133 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87614781 |
| 134 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87455185 |
| 135 | MYC_22102868_ChIP-Seq_BL_Human | 0.86322310 |
| 136 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.83849041 |
| 137 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81278738 |
| 138 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.81245540 |
| 139 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.80529420 |
| 140 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.80149754 |
| 141 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.79981219 |
| 142 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.78886131 |
| 143 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.78693453 |
| 144 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.77379531 |
| 145 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.75799185 |
| 146 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.75339360 |
| 147 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.75273581 |
| 148 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.74549672 |
| 149 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.74326735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 5.27956712 |
| 2 | MP0001529_abnormal_vocalization | 3.92512662 |
| 3 | MP0002653_abnormal_ependyma_morphology | 3.07892040 |
| 4 | MP0001905_abnormal_dopamine_level | 2.80842772 |
| 5 | MP0003880_abnormal_central_pattern | 2.74145505 |
| 6 | MP0005174_abnormal_tail_pigmentation | 2.66160664 |
| 7 | MP0006036_abnormal_mitochondrial_physio | 2.46801347 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.41177294 |
| 9 | MP0004147_increased_porphyrin_level | 2.38658517 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.34198807 |
| 11 | MP0002736_abnormal_nociception_after | 2.32206895 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.26032625 |
| 13 | MP0005409_darkened_coat_color | 2.11269598 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.09930594 |
| 15 | MP0006292_abnormal_olfactory_placode | 2.06993190 |
| 16 | MP0005075_abnormal_melanosome_morpholog | 2.00872028 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.00721002 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 1.99145600 |
| 19 | MP0006035_abnormal_mitochondrial_morpho | 1.98709825 |
| 20 | MP0003646_muscle_fatigue | 1.94560858 |
| 21 | MP0005645_abnormal_hypothalamus_physiol | 1.86878039 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 1.79047842 |
| 23 | MP0005551_abnormal_eye_electrophysiolog | 1.74995985 |
| 24 | MP0002234_abnormal_pharynx_morphology | 1.74368599 |
| 25 | MP0009046_muscle_twitch | 1.72476449 |
| 26 | MP0005671_abnormal_response_to | 1.69862931 |
| 27 | MP0009764_decreased_sensitivity_to | 1.63441038 |
| 28 | MP0002638_abnormal_pupillary_reflex | 1.63091677 |
| 29 | MP0002102_abnormal_ear_morphology | 1.63076775 |
| 30 | MP0004142_abnormal_muscle_tone | 1.62150513 |
| 31 | MP0001188_hyperpigmentation | 1.61230772 |
| 32 | MP0002163_abnormal_gland_morphology | 1.60613572 |
| 33 | MP0003763_abnormal_thymus_physiology | 1.55077640 |
| 34 | MP0002095_abnormal_skin_pigmentation | 1.54942302 |
| 35 | MP0000372_irregular_coat_pigmentation | 1.54435174 |
| 36 | MP0002876_abnormal_thyroid_physiology | 1.51961541 |
| 37 | MP0001986_abnormal_taste_sensitivity | 1.50673502 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.46942905 |
| 39 | MP0005083_abnormal_biliary_tract | 1.45121543 |
| 40 | MP0004957_abnormal_blastocyst_morpholog | 1.39965390 |
| 41 | MP0004145_abnormal_muscle_electrophysio | 1.38979346 |
| 42 | MP0001984_abnormal_olfaction | 1.33978348 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.33298652 |
| 44 | MP0003195_calcinosis | 1.32731653 |
| 45 | MP0000015_abnormal_ear_pigmentation | 1.31928220 |
| 46 | MP0004133_heterotaxia | 1.31331596 |
| 47 | MP0000685_abnormal_immune_system | 1.31250611 |
| 48 | MP0000749_muscle_degeneration | 1.27982489 |
| 49 | MP0006072_abnormal_retinal_apoptosis | 1.27725445 |
| 50 | MP0002735_abnormal_chemical_nociception | 1.26940527 |
| 51 | MP0004742_abnormal_vestibular_system | 1.26656996 |
| 52 | MP0001835_abnormal_antigen_presentation | 1.26574674 |
| 53 | MP0003866_abnormal_defecation | 1.26283516 |
| 54 | MP0003693_abnormal_embryo_hatching | 1.25579906 |
| 55 | MP0004043_abnormal_pH_regulation | 1.25491695 |
| 56 | MP0004130_abnormal_muscle_cell | 1.24878553 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.24206313 |
| 58 | MP0002398_abnormal_bone_marrow | 1.22272325 |
| 59 | MP0002272_abnormal_nervous_system | 1.22241721 |
| 60 | MP0000751_myopathy | 1.22066660 |
| 61 | MP0003011_delayed_dark_adaptation | 1.21924051 |
| 62 | MP0003787_abnormal_imprinting | 1.21073453 |
| 63 | MP0001664_abnormal_digestion | 1.19547143 |
| 64 | MP0003315_abnormal_perineum_morphology | 1.19310203 |
| 65 | MP0005670_abnormal_white_adipose | 1.17593945 |
| 66 | MP0003186_abnormal_redox_activity | 1.17130183 |
| 67 | MP0001501_abnormal_sleep_pattern | 1.16105733 |
| 68 | MP0009745_abnormal_behavioral_response | 1.15420143 |
| 69 | MP0005464_abnormal_platelet_physiology | 1.13642135 |
| 70 | MP0003635_abnormal_synaptic_transmissio | 1.12859978 |
| 71 | MP0001873_stomach_inflammation | 1.12123192 |
| 72 | MP0005389_reproductive_system_phenotype | 1.12063797 |
| 73 | MP0003724_increased_susceptibility_to | 1.10997297 |
| 74 | MP0000689_abnormal_spleen_morphology | 1.10944079 |
| 75 | MP0001853_heart_inflammation | 1.10579553 |
| 76 | MP0009278_abnormal_bone_marrow | 1.09241490 |
| 77 | MP0002160_abnormal_reproductive_system | 1.09025500 |
| 78 | MP0001919_abnormal_reproductive_system | 1.08643652 |
| 79 | MP0001790_abnormal_immune_system | 1.07329865 |
| 80 | MP0005387_immune_system_phenotype | 1.07329865 |
| 81 | MP0002067_abnormal_sensory_capabilities | 1.07293737 |
| 82 | MP0009333_abnormal_splenocyte_physiolog | 1.06889657 |
| 83 | MP0008569_lethality_at_weaning | 1.06841371 |
| 84 | MP0003137_abnormal_impulse_conducting | 1.06703159 |
| 85 | MP0001970_abnormal_pain_threshold | 1.05703709 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 1.04288251 |
| 87 | MP0002132_abnormal_respiratory_system | 1.04223379 |
| 88 | MP0002938_white_spotting | 1.02889774 |
| 89 | MP0001663_abnormal_digestive_system | 1.02615511 |
| 90 | MP0009785_altered_susceptibility_to | 1.02613108 |
| 91 | MP0002722_abnormal_immune_system | 1.02345809 |
| 92 | MP0000490_abnormal_crypts_of | 1.01884349 |
| 93 | MP0002064_seizures | 0.99625251 |
| 94 | MP0004924_abnormal_behavior | 0.99207774 |
| 95 | MP0005386_behavior/neurological_phenoty | 0.99207774 |
| 96 | MP0002733_abnormal_thermal_nociception | 0.99155090 |
| 97 | MP0000703_abnormal_thymus_morphology | 0.97792142 |
| 98 | MP0003786_premature_aging | 0.97777028 |
| 99 | MP0002420_abnormal_adaptive_immunity | 0.96964223 |
| 100 | MP0005025_abnormal_response_to | 0.95852612 |
| 101 | MP0002429_abnormal_blood_cell | 0.95837054 |
| 102 | MP0005000_abnormal_immune_tolerance | 0.95719763 |
| 103 | MP0005410_abnormal_fertilization | 0.94880155 |
| 104 | MP0001764_abnormal_homeostasis | 0.93813692 |
| 105 | MP0008932_abnormal_embryonic_tissue | 0.93734337 |
| 106 | MP0002693_abnormal_pancreas_physiology | 0.93418544 |
| 107 | MP0002734_abnormal_mechanical_nocicepti | 0.93258856 |
| 108 | MP0005084_abnormal_gallbladder_morpholo | 0.93104625 |
| 109 | MP0001819_abnormal_immune_cell | 0.92811407 |
| 110 | MP0005332_abnormal_amino_acid | 0.92466618 |
| 111 | MP0002572_abnormal_emotion/affect_behav | 0.92397933 |
| 112 | MP0001800_abnormal_humoral_immune | 0.91989085 |
| 113 | MP0004036_abnormal_muscle_relaxation | 0.91665340 |
| 114 | MP0000716_abnormal_immune_system | 0.90251481 |
| 115 | MP0000358_abnormal_cell_content/ | 0.89943170 |
| 116 | MP0003077_abnormal_cell_cycle | 0.89837841 |
| 117 | MP0004270_analgesia | 0.89712806 |
| 118 | MP0000631_abnormal_neuroendocrine_gland | 0.89356959 |
| 119 | MP0001485_abnormal_pinna_reflex | 0.88762848 |
| 120 | MP0008872_abnormal_physiological_respon | 0.88617523 |
| 121 | MP0003136_yellow_coat_color | 0.87325060 |
| 122 | MP0000750_abnormal_muscle_regeneration | 0.87248926 |
| 123 | MP0002557_abnormal_social/conspecific_i | 0.87150213 |
| 124 | MP0001440_abnormal_grooming_behavior | 0.86881152 |
| 125 | MP0000230_abnormal_systemic_arterial | 0.86050143 |
| 126 | MP0002184_abnormal_innervation | 0.86003094 |
| 127 | MP0000049_abnormal_middle_ear | 0.85755297 |
| 128 | MP0004808_abnormal_hematopoietic_stem | 0.84573872 |
| 129 | MP0008877_abnormal_DNA_methylation | 0.84483526 |
| 130 | MP0010094_abnormal_chromosome_stability | 0.84223134 |
| 131 | MP0002822_catalepsy | 0.84006349 |
| 132 | MP0008058_abnormal_DNA_repair | 0.83525604 |
| 133 | MP0005253_abnormal_eye_physiology | 0.83406965 |
| 134 | MP0002148_abnormal_hypersensitivity_rea | 0.82658630 |
| 135 | MP0004215_abnormal_myocardial_fiber | 0.81850048 |
| 136 | MP0002723_abnormal_immune_serum | 0.80909270 |
| 137 | MP0003123_paternal_imprinting | 0.80363488 |
| 138 | MP0008469_abnormal_protein_level | 0.79945820 |
| 139 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79782255 |
| 140 | MP0002751_abnormal_autonomic_nervous | 0.79703571 |
| 141 | MP0005381_digestive/alimentary_phenotyp | 0.79511255 |
| 142 | MP0002138_abnormal_hepatobiliary_system | 0.78852762 |
| 143 | MP0005448_abnormal_energy_balance | 0.77781068 |
| 144 | MP0005636_abnormal_mineral_homeostasis | 0.77582180 |
| 145 | MP0003718_maternal_effect | 0.77482588 |
| 146 | MP0005379_endocrine/exocrine_gland_phen | 0.77367722 |
| 147 | MP0003567_abnormal_fetal_cardiomyocyte | 0.77205405 |
| 148 | MP0006054_spinal_hemorrhage | 0.76033269 |
| 149 | MP0002452_abnormal_antigen_presenting | 0.75733201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.30815669 |
| 2 | Hepatocellular necrosis (HP:0001404) | 5.87983160 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 5.82414649 |
| 4 | Mitochondrial inheritance (HP:0001427) | 5.79889390 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 5.67123426 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.30302387 |
| 7 | Increased CSF lactate (HP:0002490) | 4.93742351 |
| 8 | Hepatic necrosis (HP:0002605) | 4.91610248 |
| 9 | Increased hepatocellular lipid droplets (HP:0006565) | 4.80492060 |
| 10 | Reticulocytopenia (HP:0001896) | 4.73689945 |
| 11 | Acute encephalopathy (HP:0006846) | 4.65927746 |
| 12 | Progressive macrocephaly (HP:0004481) | 4.63463690 |
| 13 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.58435742 |
| 14 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.58435742 |
| 15 | Lipid accumulation in hepatocytes (HP:0006561) | 4.44560501 |
| 16 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.43566123 |
| 17 | Macrocytic anemia (HP:0001972) | 4.36637013 |
| 18 | 3-Methylglutaconic aciduria (HP:0003535) | 4.14604468 |
| 19 | Increased serum pyruvate (HP:0003542) | 4.07260857 |
| 20 | Abnormality of glycolysis (HP:0004366) | 4.07260857 |
| 21 | Increased intramyocellular lipid droplets (HP:0012240) | 4.02387638 |
| 22 | Pallor (HP:0000980) | 3.86034921 |
| 23 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.85076379 |
| 24 | Increased serum lactate (HP:0002151) | 3.72119307 |
| 25 | Renal Fanconi syndrome (HP:0001994) | 3.71479760 |
| 26 | Lactic acidosis (HP:0003128) | 3.63192853 |
| 27 | Increased muscle lipid content (HP:0009058) | 3.62083998 |
| 28 | Exercise intolerance (HP:0003546) | 3.51113396 |
| 29 | Pancreatic cysts (HP:0001737) | 3.47035136 |
| 30 | Respiratory failure (HP:0002878) | 3.36916727 |
| 31 | Molar tooth sign on MRI (HP:0002419) | 3.33160009 |
| 32 | Abnormality of midbrain morphology (HP:0002418) | 3.33160009 |
| 33 | Congenital stationary night blindness (HP:0007642) | 3.31290381 |
| 34 | Exertional dyspnea (HP:0002875) | 3.26704660 |
| 35 | Aplastic anemia (HP:0001915) | 3.24439410 |
| 36 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.22879068 |
| 37 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.17392920 |
| 38 | Cerebral edema (HP:0002181) | 3.00991134 |
| 39 | Pancreatic fibrosis (HP:0100732) | 2.98490100 |
| 40 | Microvesicular hepatic steatosis (HP:0001414) | 2.95156142 |
| 41 | Optic disc pallor (HP:0000543) | 2.94639520 |
| 42 | Respiratory difficulties (HP:0002880) | 2.93163495 |
| 43 | Ragged-red muscle fibers (HP:0003200) | 2.83734681 |
| 44 | Emotional lability (HP:0000712) | 2.81208913 |
| 45 | Thrombocytosis (HP:0001894) | 2.77891820 |
| 46 | True hermaphroditism (HP:0010459) | 2.71262288 |
| 47 | Severe visual impairment (HP:0001141) | 2.64375614 |
| 48 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.61907707 |
| 49 | Nephronophthisis (HP:0000090) | 2.61572468 |
| 50 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.57644519 |
| 51 | Microretrognathia (HP:0000308) | 2.56330297 |
| 52 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.47535478 |
| 53 | CNS demyelination (HP:0007305) | 2.46238179 |
| 54 | Hypothermia (HP:0002045) | 2.43029596 |
| 55 | Progressive microcephaly (HP:0000253) | 2.39904749 |
| 56 | Sclerocornea (HP:0000647) | 2.38302901 |
| 57 | Concave nail (HP:0001598) | 2.34553785 |
| 58 | IgM deficiency (HP:0002850) | 2.29272367 |
| 59 | Attenuation of retinal blood vessels (HP:0007843) | 2.27670035 |
| 60 | Cerebral hypomyelination (HP:0006808) | 2.26820809 |
| 61 | Severe muscular hypotonia (HP:0006829) | 2.22992482 |
| 62 | Type I transferrin isoform profile (HP:0003642) | 2.22893565 |
| 63 | Abolished electroretinogram (ERG) (HP:0000550) | 2.22770194 |
| 64 | Petechiae (HP:0000967) | 2.22367128 |
| 65 | Leukodystrophy (HP:0002415) | 2.21372956 |
| 66 | Retinal dysplasia (HP:0007973) | 2.20171798 |
| 67 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.19405397 |
| 68 | 11 pairs of ribs (HP:0000878) | 2.18806570 |
| 69 | Neuroendocrine neoplasm (HP:0100634) | 2.18307113 |
| 70 | Type II lissencephaly (HP:0007260) | 2.17077048 |
| 71 | Mesangial abnormality (HP:0001966) | 2.15269910 |
| 72 | Medial flaring of the eyebrow (HP:0010747) | 2.09462035 |
| 73 | Oral leukoplakia (HP:0002745) | 2.07940206 |
| 74 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.06918074 |
| 75 | Abnormality of renal resorption (HP:0011038) | 2.06718330 |
| 76 | Hypoplasia of the pons (HP:0012110) | 2.05216405 |
| 77 | Pendular nystagmus (HP:0012043) | 1.99011651 |
| 78 | Abnormality of the renal medulla (HP:0100957) | 1.96281757 |
| 79 | Delusions (HP:0000746) | 1.95725069 |
| 80 | Increased cerebral lipofuscin (HP:0011813) | 1.95567159 |
| 81 | Panhypogammaglobulinemia (HP:0003139) | 1.94974501 |
| 82 | Muscle fiber atrophy (HP:0100295) | 1.94629562 |
| 83 | Hyperphosphaturia (HP:0003109) | 1.92032718 |
| 84 | Ketosis (HP:0001946) | 1.91425375 |
| 85 | Cystic liver disease (HP:0006706) | 1.90109612 |
| 86 | Progressive muscle weakness (HP:0003323) | 1.87993236 |
| 87 | Polydipsia (HP:0001959) | 1.87407990 |
| 88 | Abnormal drinking behavior (HP:0030082) | 1.87407990 |
| 89 | Decreased central vision (HP:0007663) | 1.87138140 |
| 90 | Abnormality of the pons (HP:0007361) | 1.86838115 |
| 91 | IgG deficiency (HP:0004315) | 1.85903196 |
| 92 | Dry hair (HP:0011359) | 1.85314563 |
| 93 | Pancytopenia (HP:0001876) | 1.85080374 |
| 94 | Dicarboxylic aciduria (HP:0003215) | 1.83379061 |
| 95 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.83379061 |
| 96 | Methylmalonic aciduria (HP:0012120) | 1.83143557 |
| 97 | Colon cancer (HP:0003003) | 1.83052623 |
| 98 | Gliosis (HP:0002171) | 1.82775397 |
| 99 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.82735532 |
| 100 | Absent/shortened dynein arms (HP:0200106) | 1.81662521 |
| 101 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.81662521 |
| 102 | Cerebral palsy (HP:0100021) | 1.80717730 |
| 103 | Congenital, generalized hypertrichosis (HP:0004540) | 1.79486734 |
| 104 | Polyphagia (HP:0002591) | 1.79402837 |
| 105 | Polyuria (HP:0000103) | 1.79102208 |
| 106 | Opisthotonus (HP:0002179) | 1.78515130 |
| 107 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.77622307 |
| 108 | Clumsiness (HP:0002312) | 1.76598907 |
| 109 | Unsteady gait (HP:0002317) | 1.75379499 |
| 110 | Absent thumb (HP:0009777) | 1.75311114 |
| 111 | Agitation (HP:0000713) | 1.74751709 |
| 112 | Glycosuria (HP:0003076) | 1.73174301 |
| 113 | Abnormality of urine glucose concentration (HP:0011016) | 1.73174301 |
| 114 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.73021766 |
| 115 | Agammaglobulinemia (HP:0004432) | 1.72146790 |
| 116 | Type 2 muscle fiber atrophy (HP:0003554) | 1.68175139 |
| 117 | Limb dystonia (HP:0002451) | 1.67845234 |
| 118 | Visual hallucinations (HP:0002367) | 1.67731276 |
| 119 | Ketoacidosis (HP:0001993) | 1.67381298 |
| 120 | Generalized aminoaciduria (HP:0002909) | 1.67299347 |
| 121 | Abnormal pupillary function (HP:0007686) | 1.66294558 |
| 122 | Myotonia (HP:0002486) | 1.65849518 |
| 123 | Hyperalaninemia (HP:0003348) | 1.65674013 |
| 124 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.65674013 |
| 125 | Abnormality of alanine metabolism (HP:0010916) | 1.65674013 |
| 126 | Pheochromocytoma (HP:0002666) | 1.63769360 |
| 127 | Multiple enchondromatosis (HP:0005701) | 1.59921103 |
| 128 | Abnormal protein glycosylation (HP:0012346) | 1.59662783 |
| 129 | Abnormal glycosylation (HP:0012345) | 1.59662783 |
| 130 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.59662783 |
| 131 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.59662783 |
| 132 | Depressed nasal ridge (HP:0000457) | 1.58932359 |
| 133 | Rough bone trabeculation (HP:0100670) | 1.58077709 |
| 134 | Hyperventilation (HP:0002883) | 1.56775288 |
| 135 | Prolonged bleeding time (HP:0003010) | 1.55781370 |
| 136 | Rimmed vacuoles (HP:0003805) | 1.54759308 |
| 137 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.54417430 |
| 138 | Myokymia (HP:0002411) | 1.53851635 |
| 139 | X-linked dominant inheritance (HP:0001423) | 1.51508125 |
| 140 | Cerebellar dysplasia (HP:0007033) | 1.51199277 |
| 141 | Migraine (HP:0002076) | 1.49592479 |
| 142 | Increased serum ferritin (HP:0003281) | 1.48923670 |
| 143 | Purpura (HP:0000979) | 1.48071796 |
| 144 | Lethargy (HP:0001254) | 1.48068287 |
| 145 | Amniotic constriction ring (HP:0009775) | 1.47136131 |
| 146 | Abnormality of placental membranes (HP:0011409) | 1.47136131 |
| 147 | Lissencephaly (HP:0001339) | 1.46304584 |
| 148 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.45200324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.47123111 |
| 2 | VRK2 | 4.19532129 |
| 3 | STK16 | 3.91458933 |
| 4 | MAP3K12 | 3.66864145 |
| 5 | TLK1 | 3.23106763 |
| 6 | CDK19 | 2.69621377 |
| 7 | NME1 | 2.66594612 |
| 8 | ZAK | 2.46523000 |
| 9 | WEE1 | 2.35286039 |
| 10 | FRK | 2.28575950 |
| 11 | MAP4K1 | 2.20764997 |
| 12 | MAP4K2 | 2.15401778 |
| 13 | VRK1 | 2.07834556 |
| 14 | TAOK3 | 2.00908319 |
| 15 | BUB1 | 1.99348178 |
| 16 | PIM2 | 1.95052354 |
| 17 | ARAF | 1.85115906 |
| 18 | NUAK1 | 1.80944118 |
| 19 | GRK1 | 1.78305095 |
| 20 | FLT3 | 1.72135279 |
| 21 | INSRR | 1.70284371 |
| 22 | EIF2AK1 | 1.65189841 |
| 23 | MYLK | 1.61027744 |
| 24 | BCKDK | 1.60243672 |
| 25 | KIT | 1.57923251 |
| 26 | GRK6 | 1.53910926 |
| 27 | TNIK | 1.53190130 |
| 28 | DYRK3 | 1.52234249 |
| 29 | CCNB1 | 1.50989149 |
| 30 | ACVR1B | 1.48708645 |
| 31 | IKBKB | 1.46309341 |
| 32 | BTK | 1.39579276 |
| 33 | WNK4 | 1.39296604 |
| 34 | PINK1 | 1.37535089 |
| 35 | BMPR1B | 1.35542201 |
| 36 | MAPKAPK5 | 1.33440311 |
| 37 | SYK | 1.31335122 |
| 38 | SRPK1 | 1.30277010 |
| 39 | DYRK2 | 1.28904896 |
| 40 | MUSK | 1.28771294 |
| 41 | CASK | 1.27757933 |
| 42 | DAPK2 | 1.16042038 |
| 43 | MAPK13 | 1.16021513 |
| 44 | SCYL2 | 1.15375910 |
| 45 | BLK | 1.14754401 |
| 46 | ADRBK2 | 1.12228401 |
| 47 | ILK | 1.12116143 |
| 48 | UHMK1 | 1.08233602 |
| 49 | CSF1R | 1.07821703 |
| 50 | KDR | 1.06912751 |
| 51 | TEC | 1.04035962 |
| 52 | CSNK1G3 | 1.00824710 |
| 53 | DAPK1 | 1.00780907 |
| 54 | CDK8 | 1.00091420 |
| 55 | TESK2 | 0.99248195 |
| 56 | FES | 0.97774783 |
| 57 | MAP3K11 | 0.96624353 |
| 58 | PNCK | 0.96284561 |
| 59 | MAPKAPK3 | 0.94118481 |
| 60 | GRK7 | 0.93106078 |
| 61 | ZAP70 | 0.92736992 |
| 62 | MARK1 | 0.89824854 |
| 63 | CLK1 | 0.85997002 |
| 64 | PKN1 | 0.85318239 |
| 65 | IRAK4 | 0.85094588 |
| 66 | MAP2K3 | 0.84619394 |
| 67 | TXK | 0.83338304 |
| 68 | MAP2K6 | 0.83098431 |
| 69 | BRAF | 0.82001936 |
| 70 | PHKG1 | 0.79689224 |
| 71 | PHKG2 | 0.79689224 |
| 72 | TESK1 | 0.79240330 |
| 73 | CSNK1A1L | 0.77061654 |
| 74 | MAP2K7 | 0.76152238 |
| 75 | TGFBR1 | 0.75812255 |
| 76 | PIK3CG | 0.74511956 |
| 77 | TBK1 | 0.73570643 |
| 78 | ERN1 | 0.72051907 |
| 79 | LMTK2 | 0.70897346 |
| 80 | WNK3 | 0.70856218 |
| 81 | MAPK4 | 0.70742966 |
| 82 | EIF2AK3 | 0.70276948 |
| 83 | OXSR1 | 0.69538270 |
| 84 | ADRBK1 | 0.69180417 |
| 85 | TSSK6 | 0.68863897 |
| 86 | PRKCQ | 0.68634328 |
| 87 | MINK1 | 0.68113996 |
| 88 | LYN | 0.66675228 |
| 89 | AURKA | 0.66426034 |
| 90 | DAPK3 | 0.65714242 |
| 91 | CAMK1 | 0.65682134 |
| 92 | TAF1 | 0.64946348 |
| 93 | MAP2K2 | 0.64381652 |
| 94 | MKNK1 | 0.63627717 |
| 95 | IKBKE | 0.61161469 |
| 96 | CHEK2 | 0.59878924 |
| 97 | CAMK2B | 0.58847741 |
| 98 | CAMKK2 | 0.58294617 |
| 99 | TNK2 | 0.57790417 |
| 100 | NTRK2 | 0.57349569 |
| 101 | PRKCG | 0.56203455 |
| 102 | RAF1 | 0.55918288 |
| 103 | PIK3CA | 0.54671415 |
| 104 | MATK | 0.54329884 |
| 105 | LIMK1 | 0.54102322 |
| 106 | CSNK2A2 | 0.53680434 |
| 107 | CSNK2A1 | 0.53115854 |
| 108 | ABL2 | 0.50849257 |
| 109 | STK11 | 0.48769703 |
| 110 | MAPK12 | 0.47956971 |
| 111 | RIPK4 | 0.47521386 |
| 112 | LRRK2 | 0.47505851 |
| 113 | SIK2 | 0.47288749 |
| 114 | MAP2K4 | 0.47109686 |
| 115 | CDC7 | 0.45462230 |
| 116 | RPS6KB2 | 0.44948324 |
| 117 | GRK5 | 0.44322512 |
| 118 | PTK2B | 0.44286698 |
| 119 | CSNK1G2 | 0.43787002 |
| 120 | LCK | 0.43203964 |
| 121 | CSNK1A1 | 0.42633746 |
| 122 | MKNK2 | 0.42588395 |
| 123 | CSNK1G1 | 0.42273701 |
| 124 | PRKCI | 0.42101976 |
| 125 | MAP3K4 | 0.41948598 |
| 126 | CHUK | 0.40860396 |
| 127 | MAP3K6 | 0.40813149 |
| 128 | PIM1 | 0.38960586 |
| 129 | PASK | 0.38919488 |
| 130 | RPS6KA5 | 0.38137775 |
| 131 | TIE1 | 0.37993140 |
| 132 | PRKACA | 0.37826058 |
| 133 | CDK11A | 0.36429482 |
| 134 | MARK3 | 0.35804102 |
| 135 | EEF2K | 0.35543147 |
| 136 | CAMKK1 | 0.35431395 |
| 137 | MAPK15 | 0.35263460 |
| 138 | RPS6KA6 | 0.35180893 |
| 139 | HIPK2 | 0.34682572 |
| 140 | PAK4 | 0.34071581 |
| 141 | CAMK2G | 0.34035597 |
| 142 | PRKD2 | 0.33571639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 6.88921679 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.69682291 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 4.48094792 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.84972646 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 3.29521650 |
| 6 | Alzheimers disease_Homo sapiens_hsa05010 | 3.24879926 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 3.06953002 |
| 8 | Huntingtons disease_Homo sapiens_hsa05016 | 3.03178188 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.65520730 |
| 10 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.61916870 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.49304918 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.46917377 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.38595274 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 2.10708403 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.09257282 |
| 16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.98404329 |
| 17 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.93175903 |
| 18 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.91337225 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.82937859 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.82843327 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.73362613 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.68566447 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.48760190 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.43180533 |
| 25 | Purine metabolism_Homo sapiens_hsa00230 | 1.43067755 |
| 26 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.40131670 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.36124236 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.27747512 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.25368902 |
| 30 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.20637492 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.20413403 |
| 32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.20285623 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17514475 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.17186315 |
| 35 | RNA degradation_Homo sapiens_hsa03018 | 1.13471893 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.12519243 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.11867193 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11682327 |
| 39 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.10156272 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.08885911 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08175601 |
| 42 | Peroxisome_Homo sapiens_hsa04146 | 1.03958441 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.03478256 |
| 44 | RNA transport_Homo sapiens_hsa03013 | 1.00673912 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.00342376 |
| 46 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.97094270 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.91320007 |
| 48 | Basal transcription factors_Homo sapiens_hsa03022 | 0.91041453 |
| 49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.83739064 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.83537541 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83079978 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82036418 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78998713 |
| 54 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75352154 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73514961 |
| 56 | Nicotine addiction_Homo sapiens_hsa05033 | 0.70753596 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69147701 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.68648791 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.66848236 |
| 60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.66285198 |
| 61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66199967 |
| 62 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.64879362 |
| 63 | Alcoholism_Homo sapiens_hsa05034 | 0.63019644 |
| 64 | Phototransduction_Homo sapiens_hsa04744 | 0.62324713 |
| 65 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.60151218 |
| 66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.60011114 |
| 67 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.59846418 |
| 68 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.59733593 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59294309 |
| 70 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.59082394 |
| 71 | Cell cycle_Homo sapiens_hsa04110 | 0.58797358 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56649523 |
| 73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.55574522 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55215176 |
| 75 | Olfactory transduction_Homo sapiens_hsa04740 | 0.54625608 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.52862560 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.52538280 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52259751 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.51452033 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48987727 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48149911 |
| 82 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47069041 |
| 83 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.46996377 |
| 84 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.46914981 |
| 85 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46406376 |
| 86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.46175474 |
| 87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.43583632 |
| 88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43356110 |
| 89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42762913 |
| 90 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.41654553 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41014717 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39907009 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.39222326 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39152054 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38701421 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37647459 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37338861 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36758721 |
| 99 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.36605961 |
| 100 | Taste transduction_Homo sapiens_hsa04742 | 0.36584266 |
| 101 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.35374859 |
| 102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.35134690 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34359882 |
| 104 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.34321863 |
| 105 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.33911190 |
| 106 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.29275440 |
| 107 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.28831241 |
| 108 | Salivary secretion_Homo sapiens_hsa04970 | 0.28773087 |
| 109 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.27492999 |
| 110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.27209926 |
| 111 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26734931 |
| 112 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.26734211 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.26616202 |
| 114 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.26191920 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24406423 |
| 116 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.24040835 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.21084899 |
| 118 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.20178755 |
| 119 | Morphine addiction_Homo sapiens_hsa05032 | 0.19586406 |
| 120 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.19089233 |
| 121 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.18484687 |
| 122 | Shigellosis_Homo sapiens_hsa05131 | 0.17278281 |
| 123 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.16893020 |
| 124 | Long-term depression_Homo sapiens_hsa04730 | 0.13778479 |
| 125 | Platelet activation_Homo sapiens_hsa04611 | 0.12251562 |
| 126 | GABAergic synapse_Homo sapiens_hsa04727 | 0.12045974 |
| 127 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.11685615 |
| 128 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.11466106 |
| 129 | Circadian entrainment_Homo sapiens_hsa04713 | 0.11001251 |
| 130 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.10863471 |
| 131 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.09556012 |
| 132 | Cocaine addiction_Homo sapiens_hsa05030 | 0.09162603 |
| 133 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.08782250 |
| 134 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.08516083 |
| 135 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.07417312 |
| 136 | Long-term potentiation_Homo sapiens_hsa04720 | 0.06447057 |
| 137 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.05703349 |
| 138 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.05570738 |
| 139 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.05475822 |
| 140 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.03841573 |
| 141 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.03830341 |

